Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,121,847
-$834,480 QoQ
Shares Held
11,190
-25.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#517
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Qtron Investments LLC holds $33,905,175 across 13 Drug Manufacturers - General names. AZN ranks #6 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,521 | $9,020,913 | |
| 2 | JNJ |
Johnson & Johnson
|
21,897 | $5,561,181 | |
| 3 | ABBV |
AbbVie Inc.
|
17,841 | $4,489,509 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,088 | $2,581,308 | |
| 5 | AMGN |
Amgen Inc
|
6,469 | $2,342,554 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
11,190 | $2,121,847 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,328 | $1,689,879 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,413 | $1,568,258 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,121,847 | 11,190 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,956,327 | 14,990 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||